Study of aggregation of platelets lacking the P2Y1 receptor

Drug Development Research

Volumn 52, Issue 1-2, 2001, Pages 150-155

  Fabre, Jean Etienne ^a   King, Brian F ^b   Koller, Beverly H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

ADP; P2Y1; P2Yac; Platelets; Purinoceptors; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM ION; CYCLIC AMP; PURINE P2Y RECEPTOR;

ANIMAL CELL; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONFERENCE PAPER; MOUSE; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0035030494     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.1109     Document Type: Conference Paper

References (18)

1. Born GVR. 1962. Platelet aggregation and its reversal. Nature 194:927-929.
2. Burnstock G. 1978. A basis for distinguishing two types of purinergic receptor. In: Bolis L, Strauss RW, editors. Cell membrane receptors for drugs and hormones. New York: Raven Press, p 107-118.
3. Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli S. 1998. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct receptors on human platelets. J Biol Chem 273:2024-2029.
4. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. 1999. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 5:1199-1202.
5. ADP-receptors. Br J Pharmacol 124:157-164.
6. Gaarder A, Jonsen J, Laland S, Hellem AJ, Owen PA. 1961. Adenosine diphosphate in red cells as a factor in adhesiveness of human blood platelets. Nature 192:531-532.
7. Geiger J, Hönig-Liedi P, Schanzenbächer P, Walter U. 1998. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 251:235-245.
8. Gordon JL. 1986. Extracellular ATP: effects, sources and fate. Biochem J 233:309-319.
9. Hechler B, Leon C, Vial G, Vigne P, Frelin C, Cazenave JP, Gachet C. 1998. The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 92:152-159.
10. Heennskerk JWM, Sage SO. 1994. Calcium signalling in platelets and other cells. Platelets 5:295-316.
11. Hourani SM, Cusack NJ. 1991. Pharmacological receptors on blood platelets. Pharmacol Rev 43:243-298.
12. King BE Liu M, Pintor J, Gualix J, Miras-Portugal MT, Burnstock G. 1999. Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors. Br J Pharmacol 128:981-988.
13. Lanza F, Beretz A, Stierle A, Hanau D, Kubina M, Cazenave JP. 1988. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 255:111276-111288.
14. Leon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C. 1997. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastics cells. FEBS Lett 403:26-30.
15. Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A, LeMeur M, Cazenave JP, Gachet C. 1999. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice [see Comments]. J Clin Invest 104:1731-1737.
16. 32P diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest 71:420-428.
17. i2 proteins. Biochem J 312:775-779.
18. Oury C, Toth-Zsamboki E, Van Geet C, Thys C, Wei L, Nilius B, Vermylen J, Hoylaerts ME 2000. A natural dominant negative P2X1 receptor flue to deletion of a single amino acid residue. J Biol Chem 275:22611-22614.